Type III Dysbetalipoproteinemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Evaluation of the efficacy of rosuvastatin 10mg, rosuvastatin 20mg and pravastatin 40mg in subjects with dysbetalipoproteinemia.
Epistemonikos ID: b4e773620573727ab4fb66c344bad03e42e8fd91
First added on: May 04, 2024